$1.9 Billion is the total value of Novo Holdings A/S's 51 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | Sell | VANGUARD INDEX FDStotal stk mkt | $347,322,000 | -25.6% | 1,525,550 | -21.1% | 18.32% | -17.1% |
| AAPL | Sell | APPLE INC | $106,666,000 | -34.6% | 610,879 | -33.5% | 5.63% | -27.2% |
| MORF | Sell | MORPHIC HLDG INC | $65,638,000 | -32.4% | 1,634,811 | -20.3% | 3.46% | -24.7% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $48,444,000 | +24.2% | 2,200,000 | -10.0% | 2.56% | +38.3% |
| NKTX | Sell | NKARTA INC | $31,794,000 | -25.9% | 2,793,863 | -0.0% | 1.68% | -17.4% |
| MIST | Sell | MILESTONE PHARMACEUTICALS IN | $16,243,000 | -2.0% | 2,530,003 | -0.0% | 0.86% | +9.2% |
| VECT | Sell | VECTIVBIO HLDG AG | $15,922,000 | -7.9% | 3,380,402 | -4.0% | 0.84% | +2.6% |
| Sell | MINERVA SURGICAL INC | $9,220,000 | -12.8% | 2,048,892 | -0.4% | 0.49% | -3.0% | |
| CMPI | Sell | CHECKMATE PHARMACEUTICALS IN | $6,897,000 | +10.7% | 2,161,990 | -0.4% | 0.36% | +23.4% |
| ALGS | Sell | ALIGOS THERAPEUTICS INC | $4,193,000 | -86.5% | 1,950,000 | -25.4% | 0.22% | -85.0% |
| FRLN | Exit | FREELINE THERAPEUTICS HLDGSsponsored ads | $0 | – | -1,776,613 | -100.0% | -0.17% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -555,186 | -100.0% | -0.18% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -442,550 | -100.0% | -0.34% | – |
| Exit | EXSCIENTIA PLCads | $0 | – | -13,086,600 | -100.0% | -12.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-05-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-14 |
| SC 13G/A | 2024-05-14 |
| 144 | 2024-05-10 |
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.